Bindu Popat Lewis, DO
Pain Medicine · Grand Rapids, MINPI 1548422272
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Abbott at 31.3% of the total. Reporting peaked in 2022 at $445 and has fallen 52.4% since, to $212 in 2024. That places this record below the midpoint for pain medicine clinicians in MI, where the typical reported total is $1,927.
Across 79 payments — averaging $19.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$480
- Teva Pharmaceuticals USA, Inc.$184
- AbbVie$163
- Nevro Corp.$158
- Biohaven Pharmaceutical Holding Company Ltd.$121
- Pfizer$110
- plus $318 from 11 others
Across 106 payments — averaging $1262.87 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$134K
What the payments were for
- Food & beverage$1,535100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 29 | $480 |
| Teva Pharmaceuticals USA, Inc. | 7 | $184 |
| AbbVie(2 entities) | 9 | $163 |
| Nevro Corp. | 5 | $158 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $121 |
| Pfizer | 6 | $110 |
| Boston Scientific | 3 | $51 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Amgen | 2 | $36 |
| Hydrocision, Inc. | 1 | $35 |
| Medtronic(2 entities) | 2 | $34 |
| Collegium Pharmaceutical, Inc. | 2 | $30 |
| Johnson & Johnson | 2 | $26 |
| Novartis | 1 | $25 |
| Lilly USA, LLC | 1 | $15 |
| GRT US Holding, Inc. | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $14 |
How this compares
$1,535 in reported general payments places this provider in the 45th percentile of 139 pain medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 397 | $7,512 |
| Fentanyl | 27 | $2,390 |
| Gabapentin | 176 | $1,850 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 52 | $1,016 |
| Tizanidine Hcl | 133 | $1,004 |
| Pregabalin | 67 | $826 |
| Tramadol Hcl | 100 | $644 |
| Morphine Sulfate ErMorphine Sulfate | 34 | $536 |
| Duloxetine Hcl | 17 | $511 |
| Oxycodone Hcl | 39 | $469 |
| Cyclobenzaprine Hcl | 45 | $249 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 22 | $229 |
| Topiramate | 17 | $211 |
| Amitriptyline Hcl | 30 | $198 |
| Baclofen | 18 | $178 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Grand Rapids
- Yijia ChuGrand Rapids$88K
- Peter KhouryGrand Rapids$15K
- Matthew VillerotGrand Rapids$14K
- Emilio ValdesGrand Rapids$5K
- Adam PowellGrand Rapids$5K
- Zachary NowakGrand Rapids$5K
- Kevin NemethGrand Rapids$5K
- Carl HinshawGrand Rapids$3K
- Daniel VeldheerGrand Rapids$3K
- Harry SukumaranRochester Hills$304K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.